Improved Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) Associated with Bone Marrow as the Stem Cell Source in Adults

被引：0
|
作者：
Mehta, Rohtesh S. [1 ]
deLatour, Regis Peffault [2 ]
Defor, Todd E. [1 ]
Robin, Marie [2 ]
Lazaryan, Aleksandr [3 ]
Xhaard, Alienor [2 ]
Bejanyan, Nelli [3 ]
de Fontbrune, Flore Sicre [2 ]
Arora, Mukta [3 ]
Brunstein, Claudio G. [3 ]
Blazar, Bruce R. [4 ]
Weisdorf, Daniel J. [5 ]
MacMillan, Margaret L. [4 ]
Socie, Gerard [2 ]
Holtan, Shernan [3 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] St Louis Hosp, Paris, France
[3] Univ Minnesota, Hematol Oncol & Transplantat, Minneapolis, MN USA
[4] Univ Minnesota, Dept Pediat, Blood & Marrow Transplantat, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Div Hematol Oncol & Transplantat, Med, Minneapolis, MN USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2015.11.334
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [1] Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults
    Mehta, Rohtesh S.
    de Latour, Regis Peffault
    DeFor, Todd E.
    Robin, Marie
    Lazaryan, Aleksandr
    Xhaard, Alienor
    Bejanyan, Nelli
    de Fontbrune, Flore Sicre
    Arora, Mukta
    Brunstein, Claudio G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    Socie, Gerard
    Holtan, Shernan G.
    HAEMATOLOGICA, 2016, 101 (06) : 764 - 772
  • [2] Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
    Park, Sung-Soo
    Jeon, Young-Woo
    Min, Gi June
    Park, Silvia
    Yahng, Seung-Ah
    Yoon, Jae-Ho
    Shin, Seung-Hwan
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Yoo-Jin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 63 - 72
  • [3] Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Older Patients with Myeloid Malignancies
    Nazha, Aziz
    Rybicki, Lisa
    Abounader, Donna
    Bolwell, Brian
    Dean, Robert M.
    Ferraro, Christina
    Gerds, Aaron
    Jagadeesh, Deepa
    Hamilton, Betty Ky
    Hill, Brian T.
    Kalaycio, Matt E.
    Liu, Hein
    Pohlman, Brad
    Sobecks, Ronald M.
    Starn, Jamie
    Winslow, Victoria
    Sekeres, Mikkael
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S205 - S206
  • [4] Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia
    Tan, Jie
    Wang, Ya
    Yu, Si-Jian
    Ma, Yong-Yong
    Lei, Hu-Yi
    Liu, Qi-Fa
    LEUKEMIA RESEARCH, 2017, 59 : 1 - 7
  • [5] What Predicts Success for a New Composite Endpoint: Graft-versus-Host Disease-Free and Relapse-Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation?
    Holtan, Shernan G.
    DeFor, Todd E.
    Lazaryan, Aleksandr
    Bejanyan, Nelli
    Arora, Mukta
    Blazar, Bruce R.
    MacMillan, Margaret L.
    Weisdorf, Daniel J.
    BLOOD, 2014, 124 (21)
  • [6] Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation
    Liu, Yao-Chung
    Chien, Sheng-Hsuan
    Fan, Nai-Wen
    Hu, Ming-Hung
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Chiou, Tzeon-Jye
    Tzeng, Cheng-Hwai
    Chen, Po-Min
    Liu, Jin-Hwang
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [7] Graft-versus-Host Disease-Free Relapse-Free Survival Definition for Patients with Nonmalignant Hematologic Disorders
    Salas, Maria Queralt
    Kumar, Rajat
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (02) : 428 - 428
  • [8] Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival
    Alousi, Amin
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen R.
    Arora, Mukta
    Couriel, Daniel R.
    Pidala, Joseph
    Anderlini, Paolo
    Boyiadzis, Michael
    Bredeson, Christopher N.
    Cahn, Jean-Yves
    Cairo, Mitchell S.
    Gadalla, Shahinaz M.
    Hashmi, Shahrukh K.
    Gale, Robert Peter
    Kanda, Junya
    Kamble, Rammurti T.
    Kharfan-Dabaja, Mohamed A.
    Litzow, Mark R.
    Ringden, Olle
    Saad, Ayman A.
    Schultz, Kirk R.
    Verdonck, Leo F.
    Waller, Edmund K.
    Yared, Jean A.
    Holtan, Shernan G.
    Weisdorf, Daniel J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (02) : 270 - 278
  • [9] Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Adults
    Mehta, Rohtesh S.
    Holtan, Shernan G.
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen R.
    Arora, Mukta
    Couriel, Daniel R.
    Alousi, Amin M.
    Pidala, Joseph
    Weisdorf, Daniel J.
    BLOOD, 2017, 130
  • [10] High transplanted CD34+cells are not associated with beneficial effect on graft-versus-host disease-free, relapse-free survival (GRFS) after allogeneic hematopoietic cell transplantation
    Lee, Y.
    Lee, I. H.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S217 - S218
12345